홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Hydrochloric Acid → N-hydroxy-2-(R)-{benzyl-[4-(4-chlorophenyl)piperazine-1-sulfonyl]amino}-propionamide

HRID 843003
인쇄

반응식

HRID 843003 반응식
[OH-:1].[K+].Cl.[NH2:4]O.[CH2:6]([N:13]([S:20]([N:23]1[CH2:28][CH2:27][N:26]([C:29]2[CH:34]=[CH:33][C:32]([Cl:35])=[CH:31][CH:30]=2)[CH2:25][CH2:24]1)(=[O:22])=[O:21])[C@H:14]([CH3:19])[C:15](OC)=[O:16])[C:7]1[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=1.ClC1C=CC(OC2CCNCC2)=NC=1.ClC1C=CC(N2CCNCC2)=CC=1.Cl>CO.C(Cl)Cl>[OH:1][NH:4][C:15](=[O:16])[C@H:14]([N:13]([CH2:6][C:7]1[CH:8]=[CH:9][CH:10]=[CH:11][CH:12]=1)[S:20]([N:23]1[CH2:24][CH2:25][N:26]([C:29]2[CH:34]=[CH:33][C:32]([Cl:35])=[CH:31][CH:30]=2)[CH2:27][CH2:28]1)(=[O:22])=[O:21])[CH3:19]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

9

반응물 6

HCID 313Hydrochloric AcidHCID 14797Potassium HydroxideHCID 974781-(4-Chlorophenyl)piperazineHCID 443297Hydroxyamine hydrochlorideHCID 112643295-Chloro-2-(piperidin-4-yloxy)pyridineHCID 18727246methyl 2-(R)-{benzyl-[4-(4-chlorophenyl)piperazine-1-sulfonyl]amino}-propionate

생성물 1

HCID 18727267N-hydroxy-2-(R)-{benzyl-[4-(4-chlorophenyl)piperazine-1-sulfonyl]amino}-propionamide

시약·촉매·용매 2

HCID 887Methanol용매3회HCID 6344Dichloromethane용매

실험 절차

A solution of potassium hydroxide (1.6 g, 29.2 mmol) in methanol (9.8 ml) was added to a solution of hydroxylamine hydrochloride (1.02 g, 14.6 mmol) in methanol (9.8 ml) at 0° C. After 5 min., a solution of methyl 2-(R)-{benzyl-[4-(4-chlorophenyl)piperazine-1-sulfonyl]amino}-propionate (1.101 g, 2.44 mmol) in methanol (9.8 ml), [prepared as described in Example 2, Step, 2, but replacing D-valinesulfamoyl chloride methyl ester and 4-(5-chloropyridin-2-yloxy)piperidine with D-alaninesulfamoyl chloride methyl ester and 4-(4-chlorophenyl)-piperazine respectively, followed by benzylation as described in Example 4] was added and the reaction temperature was allowed to rise to RT. After 5 h, the reaction mixture was diluted with methylene chloride (147 ml) and neutralized with 10% aqueous HCl. The solvent was removed in vacuo and the residue was dissolved in methanol. The insoluble salts were filtered off and N-hydroxy-2-(R)-{benzyl-[4-(4-chlorophenyl)piperazine-1-sulfonyl]amino}-propionamide was isolated using reverse phase preparative HPLC (20-70% acetonitrile/0.1% aqueous trifluoroacetic acid) as a crystalline solid (23%).

후처리

  1. additionwas added
  2. customto rise to RT
  3. waitAfter 5 h
  4. customThe solvent was removed in vacuo
  5. dissolutionthe residue was dissolved in methanol
  6. filtrationThe insoluble salts were filtered off

출처 및 근거

ORD 기록
ord-7b8d7f084bcb40ac880db4910054a7e0
출처 데이터셋
uspto-grants-2002_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US06376506B1

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트